I agree, I think in terms of SP appreciation and speed, some form of partnership is key. That being said if we show great phase 3 safety (Trail stoppage) this week or next it’s game, set, match.
If CD10 leads to a phase 3, while it may be a little disappointing, I think it would almost certainly lead to some form of partnership with big pharma. NP mentioned that companies are waiting to see the data, and I’m sure they are being kept in the loop. Even if the data is just “good” some large pharma will certainly want take a few bites out of our LARGE slice of the COVID pie. If/when this happens we’ll see a significant rise in SP and an increased speed to market. I think this possibility is overlooked by some on the board. However I do understand that large swings in the share price are nerve racking.
If CD10 leads to a phase 3, while it may be a little disappointing, I think it would almost certainly lead to some form of partnership with big pharma. NP mentioned that companies are waiting to see the data, and I’m sure they are being kept in the loop. Even if the data is just “good” some large pharma will certainly want take a few bites out of our LARGE slice of the COVID pie. If/when this happens we’ll see a significant rise in SP and an increased speed to market. I think this possibility is overlooked by some on the board. However I do understand that large swings in the share price are nerve racking.
2
